期刊文献+

氟伐他汀对系膜细胞增殖及Ⅳ型胶原表达的影响

Effects: of Fluvastatin on the Cellular Proliferation and the Expression of Type Ⅳ Collagen in Mesangial Cells
下载PDF
导出
摘要 目的:观察氟伐他汀(Flu)对转化生长因子β_1(TGF-β_1)诱导下的大鼠肾小球系膜细胞(MCs)增殖和Ⅳ型胶原(ColⅣ)表达的影响,探讨其肾脏保护作用的可能机制。方法:选择处于对数生长期的MCs,分成对照组,TGF-β_1组,TGF-β_1加不同浓度Flu诱导组,采用MTT法检测MCs增殖,ELISA法检测ColⅣ表达。结果:在TGF-β_1诱导下,MCs的增殖随着Flu浓度的增加而逐渐下降,1μmol/LFlu即可明显抑制MCs增殖,P<0.01。TGF-β_1诱导下的MCs ColⅣ的表达随着Flu浓度的增加而逐渐下降,0.1μmol/L Flu即能明显抑制ColⅣ蛋白的表达,P<0.01。结论:氟伐他汀可呈剂量依赖性地抑制TGF-β_1诱导下MCs的增殖及MCs ColⅣ蛋白的表达,从而发挥其肾脏保护作用。 Objective:To investigate the effects of fluvastatin (Flu) on the cellular proliferation and the expression of type Ⅳ collagen ( ColⅣ ) in rat mesangial cells (MCs) induced by transforming growth factor-β1 (TGF-β1) ,and to explore the possible mechanisms of Flu for renoprotection. Methods:MCs were divided into the following groups according to different factors:Control group, TGF-β1 group, TGF-β1+ Fluvastatin (different concentration) group. The cellular proliferation was detected by MTT. The secretion of ColⅣ protein was quantitated by ELISA. Results:Flu could inhibit the proliferation of MCs induced by 5ng/ml TGF-β1 in a dose-dependent manner, 1μmol/L Flu could just suppress the proliferation significantly,P 〈0. 01. Flu could inhibit the expression of Col Ⅳ in MCs induced by 5ng/ml TGF-β1 in a dose-dependent manner :0. 1 μmol/L Flu could just suppress the expression of ColⅣ significantly, P 〈 0. 01. Conclusions:Fluvastatin can inhibit the cellular proliferation and the high expression of ColⅣ induced by TGF-β1 in a dose-dependent manner.
出处 《中国医药导刊》 2009年第4期630-631,634,共3页 Chinese Journal of Medicinal Guide
关键词 氟伐他汀 系膜细胞 细胞增殖 Ⅳ型胶原 Fluvastatin Mesangial cells Cell proliferation Type Ⅳ collagen
  • 相关文献

参考文献13

  • 1Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-beta in renal disease. Kidney Blood Press Res, 1998 ;21 ( 1 ) : 1- 12
  • 2万建新,吴可贵.转化生长因子-β对人肾小球系膜细胞结缔组织生长因子及细胞外基质成分表达的影响[J].中国中西医结合肾病杂志,2006,7(4):201-204. 被引量:9
  • 3Buemi M, Senatore M, Corica F, et al. Statins and progressive renal disease,Meal Res Rev,2002;22( 1 ) :76 -84
  • 4Kosmas I. Paraskevas. Statin therapy in peritoneal dialysis patients:effects beyond lipid lowering,lnt Urol Nephrol,2008 ;40:165 - 170
  • 5Harm H. H Feringa, Stefanos E. Karagiannis, Michel Chonehol, et al. Lower Progression Rate of End-Stage Renal disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitots, J Am Soe Nephrol,2007 ; 18 : 1872 - 1879
  • 6Zoran Todorovic, Zorica Nesic, Radan Stojanovic, et al. Acute Protective Effects of Simvastatin in the Rat Model of Renal Ischemia-Reperfusion Injury:It is Never Too Late for the Pretreatrnent, J Pharmacol Sci,2008;107:465 -470
  • 7Hirai A, Nakamura S, Noguchi Y, et al. C, eranlygeranylated rho small GT- Pase(s) are essential for the degradation of p27kipl and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells, J Biol Chem,1997 ;272( 1 ) :13 - 16
  • 8Ghosh PM, Mort GE, Ghosh-Choudhury N,et al. Lowtatin induces apoptosis by inhibiting mitotic and postmitotic events in cultured mesangial cells. Biochim Biophys Acta, 1997,1359 ( 1 ) : 13 - 24
  • 9万建新,郑桂安,吴可贵,陈怡,许昌声.阿托伐他汀对系膜增殖性肾炎大鼠平滑肌肌动蛋白和转化生长因子β_1表达的影响[J].高血压杂志,2006,14(2):119-123. 被引量:4
  • 10Nogaki F, Muso E, Yashim M, et al. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells, Kidney Int Suppl, 1999 ;71 : S198 - 201

二级参考文献15

  • 1Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats[J].Nephrol Dial Transplant,2003,18:265-272.
  • 2Tonolo G, Melis MG, Formato M, et al. Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients[J].Eur J Clin Invest,2000,30:980-987.
  • 3Holstein SA, Wohlford-Lenane CL, Hohl RJ, et al. Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, and RhoB[J].J Biol Chem,2002,277:10678-10682.
  • 4Johnson RJ, Iida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. α-smooth muscle actin is a marker of mesangial cell proliferation[J].J Clin Invest,1991,87:847-858.
  • 5Iwano M, Akai Y, Fujii Y, et al. Intraglomerular expression of transforming growth factor-β1 (TGF-β1) mRNA in patients with glomerulonephritis: quantitative analysis by competitive polymerase chain reaction[J].Clin Exp Immunol,1994,97:309-314.
  • 6Kim SI, Han DC, Lee HB. Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells[J].J Am Soc Nephrol,2000,11:80-87.
  • 7Park IS,Kiyomoto H,Abboud SL,et al.Expression of transforming growth factor-β and type Ⅳ collagen in early streptozotocin-induced diabetes.Diabetes,1997,46 (5):473-480.
  • 8Riser BL,Denichilo M,Cortes P,et al.Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.J Am Soc Nephrol,2000,11 (1):25-28.
  • 9Heusinger RJ,Eberlein M,Wahab NA,et al.Expression of connective tissue growth factor in human renal fibroblasts:regulatory roles of RhoA and camp.J Am Soc Nephrol,2001,12(9):1853-1861.
  • 10Grotendorst GR.Connective tissue growth factor:a mediator of TGF-β action on fibroblasts.Cytokine Growth Factor Rev,1997,8(3):171-179.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部